Acceleron axes 40% of staff in wake of Shire deal
This article was originally published in Scrip
Executive Summary
Acceleron Pharma reportedly cut 40% of its staff or around 56 positions late last month, less than two months after signing a $500 million deal with Shire (scripintelligence.com, 9 September 2010).